Patents Assigned to Abbott Diabetes Care Inc.
  • Publication number: 20200016338
    Abstract: Methods and systems for delaying alarms that include detecting an analyte level using an analyte sensor; and delaying the annunciation of an analyte alarm after the analyte level crosses an analyte threshold, wherein the delay is based on one or both of (1) a magnitude of difference between the analyte level and the analyte threshold and (2) a duration of time in which the analyte level has crossed the analyte threshold.
    Type: Application
    Filed: September 4, 2019
    Publication date: January 16, 2020
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Mark Sloan, Marc B. Taub, Gary A. Hayter, Wesley Scott Harper, Erwin S. Budiman, Charles Wei
  • Patent number: 10531831
    Abstract: Systems, devices, and methods are provided for a non-rigid wearable device comprising electrical circuitry and a support structure supporting the electrical circuitry. The support structure having rigid sections that rigidly support components of the electrical circuitry to protect components and/or solder joints from stress due to deflection and having non-rigid or flexible sections where there are no solder connections present on the electrical circuitry and/or where there are interconnecting traces present on the electrical circuitry that can tolerate stress due to deflection.
    Type: Grant
    Filed: May 13, 2016
    Date of Patent: January 14, 2020
    Assignee: ABBOTT DIABETES CARE INC.
    Inventor: Louis G. Pace
  • Publication number: 20190381244
    Abstract: Method and apparatus including calling, retrieving and/or initiating a programmed function in conjunction with execution of one or more commands related to a closed loop control algorithm, receiving one or more data in response to the one or more commands over a data interface, and executing the one or more commands related to the closed loop control algorithm based on the received one or more data are provided.
    Type: Application
    Filed: June 25, 2019
    Publication date: December 19, 2019
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Marc Barry Taub, Daniel Milfred Bernstein, Gary Alan Hayter, Mark Kent Sloan, Glenn Howard Berman, Saeed Nekoomaram
  • Publication number: 20190365296
    Abstract: Analyte sensor connectors that connect analyte sensors, e.g., conductive members of analyte sensors, to other devices such as sensor electronics units, e.g., sensor control units, are provided. Also provided are systems that include analyte sensors, analyte sensor connectors, and analyte sensor electronics units, as well as methods of establishing and maintaining connections between analyte sensors and analyte sensor electronics units, and methods of analyte monitoring/detection. Also provided are methods of making analyte sensor connectors and systems that include analyte sensor connectors.
    Type: Application
    Filed: June 17, 2019
    Publication date: December 5, 2019
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Mohammad E. Moein, Louis G. Pace, Udo Hoss, Phu X. Le, Samuel M. Curry
  • Patent number: 10493202
    Abstract: Method of monitoring a control operation of a medication delivery system, determining whether a signal level received from an analyte sensor is associated with a fault condition and a potential fault condition, and adjusting a medication delivery rate executed by the control operation when it is determined that the signal level from the analyte sensor is associated with one of the fault condition or the potential fault condition, where the medication delivery rate is adjusted to a first predetermined range when the signal level is associated with the fault condition, and adjusted to a second predetermined range when the signal level is associated with the potential fault condition is provided. Devices, systems and kits for implementing the afore-mentioned method are also provided.
    Type: Grant
    Filed: February 20, 2017
    Date of Patent: December 3, 2019
    Assignee: Abbott Diabetes Care Inc
    Inventor: Gary Alan Hayter
  • Patent number: 10492685
    Abstract: Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user.
    Type: Grant
    Filed: August 31, 2015
    Date of Patent: December 3, 2019
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Daniel Milfred Bernstein, Martin J. Fennell, Mark Kent Sloan, Michael Love, Lei He, Christopher Allen Thomas, Udo Hoss, Benjamin Jay Feldman, Kenneth J. Doniger, Gary Ashley Stafford, Gary Alan Hayter, Phillip Yee, Namvar Kiaie, Jean-Pierre Cole, Marc Barry Taub, Louis George Pace, Jeffery Mario Sicurello
  • Patent number: 10497473
    Abstract: Systems, devices, and methods are provided that enable the revision of RF command handling software stored in ROM, and that enable to supplementation of RF command handling software stored in ROM. Examples of the systems, devices, and methods make use of a lookup data structure stored within writable non-volatile memory.
    Type: Grant
    Filed: November 18, 2015
    Date of Patent: December 3, 2019
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Xuandong Hua, Jean-Pierre Cole, Martin Fennell, Theodore J. Kunich, Lane Westlund, Arni Ingimundarson
  • Patent number: 10478108
    Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.
    Type: Grant
    Filed: February 5, 2016
    Date of Patent: November 19, 2019
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Howard Wolpert, Adam Heller
  • Patent number: 10463288
    Abstract: Methods and devices to detect analyte in body fluid are provided. Embodiments include positioning an analyte sensor in fluid contact with an analyte, detecting an attenuation in a signal from an analyte sensor after positioning during a predetermined time period, categorizing the detected attenuation in the analyte sensor signal based, at least in part, on one or more characteristics of the signal, performing signal processing to generate a reportable data associated with the detected analyte sensor signal during the predetermined time period, managing if and when to request additional reference signal measurements, and managing if and when to temporarily not display results.
    Type: Grant
    Filed: August 11, 2017
    Date of Patent: November 5, 2019
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Wesley Scott Harper, Timothy Christian Dunn, Erwin Satrya Budiman, Kenneth J. Doniger, Gary Alan Hayter
  • Patent number: 10463310
    Abstract: Methods and apparatus for providing data processing and control for use in a medical communication system are provided.
    Type: Grant
    Filed: September 7, 2015
    Date of Patent: November 5, 2019
    Assignee: Abbott Diabetes Care Inc.
    Inventor: Gary Alan Hayter
  • Publication number: 20190331658
    Abstract: Methods, devices, and systems are provided for identifying dropouts in analyte monitoring system sensor data including segmenting sensor data into a plurality of time series wherein each time series is associated with a different instance of a repeating event, selecting a first time series to analyze for dropouts from the plurality of time series; comparing the selected first time series to a second time series among the plurality of time series, determining whether the selected first time series includes a portion that is more than a predefined threshold lower than a corresponding portion of the second time series, and displaying, on a computer system display, an indication that the selected first time series includes a dropout if the selected first time series includes a portion that is more than the predefined threshold lower than the corresponding portion of the second time series.
    Type: Application
    Filed: July 8, 2019
    Publication date: October 31, 2019
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Junli Ou, Erwin Satrya Budiman
  • Patent number: 10456091
    Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.
    Type: Grant
    Filed: November 5, 2018
    Date of Patent: October 29, 2019
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Wesley Scott Harper, Annie C. Tan, Timothy Christian Dunn, Mark Kent Sloan, Kenneth J. Doniger, Michael Love, Phillip Yee, Gary Alan Hayter, R. Curtis Jennewine, Glenn Howard Berman
  • Publication number: 20190320947
    Abstract: A lactate-responsive enzyme may form the basis for lactate detection and quantification using an electrochemical analyte sensor. Various features may be incorporated within an analyte sensor containing a lactate-responsive enzyme, particularly lactate oxidase, to improve sensitivity and response stability of the analyte sensor. Such analyte sensors may comprise: a working electrode having an active area disposed thereon, and a mass transport limiting membrane overcoating at least the active area upon the working electrode. The active area comprises at least a polymer, an albumin, and a lactate-responsive enzyme that is covalently bonded to the polymer. The mass transport limiting membrane may comprise at least a crosslinked polyvinylpyridine homopolymer or copolymer. The analyte sensors may determine a lactate concentration in a biological fluid, particularly in vivo, which may be correlated to various physiological conditions.
    Type: Application
    Filed: January 28, 2019
    Publication date: October 24, 2019
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Kuan-Chou Chen, Tianmei Ouyang, Stephen Oja, Benjamin Feldman, Hyun Cho, Lam Tran, Mark Eshoo
  • Patent number: 10448834
    Abstract: Method and system for providing diabetes management is provided.
    Type: Grant
    Filed: October 5, 2017
    Date of Patent: October 22, 2019
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: R. Curtis Jennewine, Kimberley J. Krapek
  • Patent number: 10433773
    Abstract: Systems, methods and apparatus are provided for rejecting noise from sparsely sampled analyte sensor data. Embodiments of the present disclosure include receiving a raw set of sensor data from an on-body device including an in vivo analyte sensor, determining an interpolation-based estimate of an analyte level over time based on the raw set of sensor data, determining an extrapolation-based estimate of the analyte level over time based on the raw set of sensor data, determining a combined estimate of the analyte level over time based on the interpolation-based estimate and the extrapolation-based estimate, and displaying a representation of the combined estimate of the analyte level over time on an output device. Numerous additional aspects are disclosed.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: October 8, 2019
    Assignee: Abbott Diabetes Care Inc.
    Inventor: Erwin Satrya Budiman
  • Patent number: 10429250
    Abstract: Disclosed herein are methods and systems for conserving energy of a power source of an analyte monitoring device. Also disclosed herein are methods and systems for reducing noise during data transmissions to and from the analyte monitoring device.
    Type: Grant
    Filed: March 26, 2015
    Date of Patent: October 1, 2019
    Assignee: Abbott Diabetes Care, Inc.
    Inventors: Saeed Nekoomaram, Martin J. Fennell, Mark Kent Sloan, Lei He, Jeffery Mario Sicurello
  • Publication number: 20190282137
    Abstract: Devices and methods for positioning a portion of a sensor at a first predetermined location, displacing the portion of the sensor from the first predetermined location to a second predetermined location, and detecting one or signals associated with an analyte level of a patient at the second predetermined location are disclosed. Also provided are systems and kits for use in analyte monitoring.
    Type: Application
    Filed: June 3, 2019
    Publication date: September 19, 2019
    Applicant: Abbott Diabetes Care Inc.
    Inventor: Gary Ashley Stafford
  • Publication number: 20190274597
    Abstract: Method and system for determining real time analyte concentration including an analyte sensor having a portion in fluid contact with an interstitial fluid under a skin layer, an on-body electronics including a housing coupled to the analyte sensor and configured for positioning on the skin layer, the on-body electronics housing including a plurality of electrical contacts , on the housing; and a data analysis unit having a data analysis unit housing and a plurality of probes , on the housing. Each of the probes configured to electrically couple to a respective electrical contact when the data analysis unit is positioned in physical contact with the on-body electronics. The one or more signals on the probes correspond to one or more of a substantially real time monitored analyte concentration level (MACL), MACL over a predetermined time period, or a rate of change of the MACL, or combinations thereof, are provided.
    Type: Application
    Filed: May 14, 2019
    Publication date: September 12, 2019
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Udo Hoss, Benjamin J. Feldman, Zenghe Liu, Hyun Cho, Benjamin M. Rush
  • Patent number: 10406286
    Abstract: Methods, system and devices for monitoring a plurality of parameters associated with a closed loop control operation including continuously monitoring a physiological condition and automatic administration of a medication, detecting an impending administration of the medication level exceeding a predetermined threshold level, retrieving one or more signals associated with the monitored physiological condition, determining an accuracy indication of the retrieved one or more signals associated with the monitored physiological condition, and executing the administration of the medication level based on the accuracy indication are provided.
    Type: Grant
    Filed: April 16, 2018
    Date of Patent: September 10, 2019
    Assignee: Abbott Diabetes Care Inc.
    Inventor: Gary Hayter
  • Patent number: 10405747
    Abstract: A glucose monitoring system, includes a glucose sensor strip or package of strips. The strip includes a substrate and a glucose monitoring circuit that has electrodes and a bodily fluid application portion of selected chemical composition. An antenna is integrated with the glucose sensor strip. A RFID sensor chip is coupled with the glucose sensor strip and the antenna. The chip has a memory containing digitally-encoded data representing calibration and/or expiration date information for the strip.
    Type: Grant
    Filed: January 23, 2018
    Date of Patent: September 10, 2019
    Assignee: Abbott Diabetes Care, Inc.
    Inventors: Timothy T. Goodnow, Lei (Lawrence) He